Pemetrexed Accord

(pemetrexed)

Uses, side effects, dosage information & price range

Accord Healthcare S.L.U.

About this medicine

Malignant pleural mesothelioma Pemetrexed Accord in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. Non-small cell lung cancer Pemetrexed Accord in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. Pemetrexed Accord is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. Pemetrexed Accord is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

AlimtaComposition: pemetrexedEli Lilly Nederland B.V.

Price on RequestView Details →

Pemetrexed Pfizer (previously Pemetrexed Hospira)Composition: pemetrexedPfizer Europe MA EEIG

Price on RequestView Details →

Armisarte (previously Pemetrexed Actavis)Composition: pemetrexedActavis Group PTC ehf

Price on RequestView Details →

Pemetrexed medacComposition: pemetrexedmedac Gesellschaft für klinische Spezialpräparate mbH

Price on RequestView Details →

Pemetrexed Fresenius KabiComposition: pemetrexedFresenius Kabi Deutschland GmbH

Price on RequestView Details →

Key Information

Salt / Composition

pemetrexed